Detalhe da pesquisa
1.
Optimal dose of buprenorphine in opioid use disorder treatment: a review of pharmacodynamic and efficacy data.
Drug Dev Ind Pharm
; 46(1): 1-7, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914818
2.
Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers.
Drug Dev Ind Pharm
; 41(1): 79-84, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24099551
3.
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder.
Neuropsychopharmacology
; 49(6): 1050-1057, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200140
4.
Oxycodone-related deaths in Sweden 2006-2018.
Drug Alcohol Depend
; 234: 109402, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306392
5.
Methadone-related deaths among youth and young adults in Sweden 2006-15.
Addiction
; 116(2): 319-327, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533568
6.
Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.
Drug Alcohol Depend
; 220: 108492, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482572
7.
Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.
Patient Prefer Adherence
; 15: 1259-1267, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34163143
8.
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
JAMA Netw Open
; 4(5): e219041, 2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33970256
9.
What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine.
Expert Opin Drug Deliv
; 16(9): 907-914, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364884
10.
Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
J Addict Dis
; 35(4): 325-338, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27267785
11.
Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial.
Clin Ther
; 37(10): 2244-55, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412801
12.
Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis.
J Neuroimmunol
; 152(1-2): 183-90, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15223251
13.
Lack of association of CCR2-64I and CCR5-Delta 32 with type 1 diabetes and latent autoimmune diabetes in adults.
Hum Immunol
; 64(6): 629-32, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12770795
14.
Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis.
Int J Mol Med
; 12(5): 749-53, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14533004
15.
[Chemokines a hope of specific anti-inflammatory treatment]. / Kemokiner ger hopp om specifik antiinflammatorisk behandling.
Lakartidningen
; 99(10): 1056-9, 2002 Mar 07.
Artigo
em Sueco
| MEDLINE | ID: mdl-12024779
16.
[Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time]. / Citalopram inte riskfritt från hjärtsynpunkt. SSRI-preparat kan ge förlängd QTc-tid.
Lakartidningen
; 103(14): 1112-4, 2006.
Artigo
em Sueco
| MEDLINE | ID: mdl-16681095
17.
Increased CD8+ central memory T cells in patients with multiple sclerosis.
Mult Scler
; 13(2): 149-55, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17439879
18.
Increased central memory T cells in patients with chronic pancreatitis.
Pancreatology
; 5(2-3): 177-82, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15849488
19.
Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome.
Arthritis Rheum
; 48(11): 3187-201, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14613282